SciCombinator

Discover the most talked about and latest scientific content & concepts.

A Kavanaugh, PJ Mease, JJ Gomez-Reino, AO Adebajo, J Wollenhaupt, DD Gladman, E Lespessailles, S Hall, M Hochfeld, C Hu, D Hough, RM Stevens and G Schett
Abstract
Apremilast, an oral phosphodiesterase 4 inhibitor, regulates inflammatory mediators. Psoriatic Arthritis Long-term Assessment of Clinical Efficacy 1 (PALACE 1) compared apremilast with placebo in patients with active psoriatic arthritis despite prior traditional disease-modifying antirheumatic drug (DMARD) and/or biologic therapy.
Tweets*
6
Facebook likes*
0
Reddit*
0
News coverage*
4
Blogs*
1
SC clicks
0
Concepts
Pharmacology, Disease-modifying antirheumatic drug, Placebo, Hydroxychloroquine, Clinical trial, Psoriatic arthritis, Methotrexate, Rheumatoid arthritis
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com